|
1）Alagesan S, Griffin MD. Alternatively activated macrophages as therapeutic agents for kidney disease: in vivo stability is a key factor. Kidney Int. 2014; 85: 730-3
|
|
|
|
2）Anders HJ, Ryu M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int. 2011; 80: 915-25
|
|
|
|
|
|
3）Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012; 122: 787-95
|
|
|
|
|
|
4）Furuhashi K, Tsuboi N, Shimizu A, et al. Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages. J Am Soc Nephrol. 2013; 24: 587-603
|
|
|
|
|
|
5）Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014; 41: 14-20
|
|
|
|
|
|
6）Tipping PG, Leong TW, Holdsworth SR. Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab Invest. 1991; 65: 272-9
|
|
|
|
|
|
7）Diamond JR, Pesek-Diamond I. Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: role of macrophages. Am J Physiol. 1991; 260(6 Pt 2): F779-86
|
|
|
|
|
|
8）van Goor H, van der Horst ML, Fidler V, et al. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. Lab Invest. 1992; 66: 564-71
|
|
|
|
|
|
9）Day YJ, Huang L, Ye H, et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol. 2005; 288: F722-31
|
|
|
|
|
|
10）Jo SK, Sung SA, Cho WY, et al. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant. 2006; 21: 1231-9
|
|
|
|
|
|
11）Ko GJ, Boo CS, Jo SK, et al. Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant. 2008; 23: 842-52
|
|
|
|
|
|
12）Duffield JS, Tipping PG, Kipari T, et al. Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am J Pathol. 2005; 167: 1207-19
|
|
|
|
|
|
13）Ikezumi Y, Suzuki T, Karasawa T, et al. Contrasting effects of steroids and mizoribine on macrophage activation and glomerular lesions in rat thy-1 mesangial proliferative glomerulonephritis. Am J Nephrol. 2010; 31: 273-82
|
|
|
|
|
|
14）Aki K, Shimizu A, Masuda Y, et al. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis. Am J Physiol Renal Physiol. 2010; 298: F870-82
|
|
|
|
|
|
15）Fujita E, Shimizu A, Masuda Y, et al. Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages. Am J Pathol. 2010; 177: 1143-54
|
|
|
|
|
|
16）Cao Q, Wang C, Zheng D, et al. IL-25 induces M2 macrophages and reduces renal injury in proteinuric kidney disease. J Am Soc Nephrol. 2011; 22: 1229-39
|
|
|
|
|
|
17）Wilson HM, Stewart KN, Brown PA, et al. Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Mol Ther. 2002; 6: 710-7
|
|
|
|
|
|
18）Kluth DC, Ainslie CV, Pearce WP, et al. Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis. J Immunol. 2001; 166: 4728-36
|
|
|
|
|
|
19）Lee S, Huen S, Nishio H, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol. 2011; 22: 317-26
|
|
|
|
|
|
20）Wang Y, Wang YP, Zheng G, et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int. 2007; 72: 290-9
|
|
|
|
|
|
21）Cao Q, Wang Y, Zheng D, et al. IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. J Am Soc Nephrol. 2010; 21: 933-42
|
|
|
|
|
|
22）Cao Q, Wang Y, Zheng D, et al. Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivo. Kidney Int. 2014; 85: 794-806
|
|
|
|
|
|
23）Shi Y, Tsuboi N, Furuhashi K, et al. Pristane-induced granulocyte recruitment promotes phenotypic conversion of macrophages and protects against diffuse pulmonary hemorrhage in Mac-1 deficiency. J Immunol. 2014; 193: 5129-39
|
|
|
|
|
|
24）Du Q, Tsuboi N, Sugiyama Y, et al. editors. Transfused M2 macrophages ameliorate renal injury in murine nephrotoxic serum nephritis. Nephrol Dial Transplant; London. 2015; 30(suppl3): iii401
|
|
|
|
|
|
25）Ikezumi Y, Suzuki T, Karasawa T, et al. Identification of alternatively activated macrophages in new-onset paediatric and adult immunoglobulin A nephropathy: potential role in mesangial matrix expansion. Histopathology. 2011; 58: 198-210
|
|
|
|
|
|
26）Zhao L, David MZ, Hyjek E, et al. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN. Clin J Am Soc Nephrol. 2015; 10: 54-62
|
|
|
|
|
|
27）Tsuboi N, Endo N, Matsuo S, et al. Association of glomerular macrophage phenotypes and urine soluble CD163 with disease activity in human lupus nephritis. Arthritis Rheum. 2014; 66: S727
|
|
|
|
|